GEN Exclusives

More »

GEN News Highlights

More »
Jul 3, 2008

PerkinElmer Creates Center to Advance Cord Blood Stem Cell Studies

  • PerkinElmer has established the ViaCord Research Institute™ (VRI™) to focus on investigating potential uses of umbilical cord blood-derived stem cells.

    VRI will concentrate on supporting science, technology, and medical treatments using cord blood stem cells in five key areas: cord blood technologies, emerging stem cell therapies, genetic screening, product development and related transplants.

    The institute will be led by a team of scientists and physicians including leading experts in the areas of stem cell biology, maternal-fetal medicine, obstetrics and gynecology, transplant medicine, and genetics.

    Cord blood is a noncontroversial source of stem cells with proven effect in treating more than 70 serious diseases including many cancers and immunodeficiencies, according to the PerkinElmer.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Using CRISPRs to Tame GMOs

With more climate-induced droughts and insect infestations on the horizon do you think technologies like CRISPR will change a lot of people’s minds about GMOs, including genetically engineered foods?

More »